Sort by
Refine Your Search
-
Listed
-
Field
-
Apply online now: https://karriere.klinikum.uni-heidelberg.de/index.php?ac=application&jobad_id=25892 PhD Position in Molecular Mechanisms of Human Infertility (m/f/d) Stellenanzeige merken
-
mechanisms of inherited kidney disorders as a prelude to improving prevention, diagnosis and treatment of common kidney disease. Currently, we have a major interest in studying lipid metabolism in kidney
-
learning, as well as process-based models integrating thermal biology mechanisms. Funded by the ”Federal Ministry of Research, Technology and Space” (BMFTR), CSIDlab as part of the “Vector-borne disease
-
material function. For gaining fundamental insights into the underlying mechanisms, we use and develop time-resolved spectroscopic techniques from the X-ray to the IR regime. The SFB 1249, a collaborative
-
Plasticity in Myeloid Malignancies: From Mechanisms to Therapies” and funded by the Deutsche Forschungsgemeinschaft. Wihtin this CRC, we will focus on new intrinsic and extrinsic factors that enable and
-
“Multi-modal proteomics to understand and overcome niche-related adaptive drug-resistance mechanisms in FLT3-mutated AML“ we are looking for a PhD student. The project is is part of the SFB/CRC 1709
-
“Cellular Plasticity in Myeloid Malignancies: From Mechanisms to Therapies”. In this CRC we will focus on myeloid malignancies as a model to dissect the various molecular mechanisms that enable and regulate
-
mechanistic and clinical studies. To expand our activities, we are looking for a motivated PhD student to investigate mechanisms of disease and drug resistance in myeloid leukemia. Job-ID: V000014484 Field
-
: From Mechanisms to Therapies”. In this CRC we aim to understand how plasticity i.e. non-genetic adaptations of the bone marrow niche induced by the disease or therapeutic agents contribute to drug
-
Malignancies: From Mechanisms to Therapies”. In this CRC we will focus on myeloid malignancies as a model to dissect the various molecular mechanisms that enable and regulate cancer cell plasticity in AML. Our